𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cumulative rate of relapse of lupus nephritis after successful treatment with cyclophosphamide

✍ Scribed by Elena Ciruelo; Javier de la Cruz; Ignacio López; Juan J. Gómez-reino

Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
724 KB
Volume
39
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The economic impact of treatment of seve
The economic impact of treatment of severe lupus nephritis with prednisone and intravenous cyclophosphamide
✍ Pamela M. Mcinnes; James Schuttinga; William R. Sanslone; Susan P. Stark; John H 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 709 KB

Objective. It has been reported that outcomes are improved in patients with severe lupus nephritis treated with combined prednisone and intravenous cyclophosphamide, compared with those treated with prednisone alone. These findings motivated this analysis of the economic impact of the combined thera

Predictors and outcome of renal flares a
Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis
✍ Chi Chiu Mok; King Yee Ying; Sydney Tang; Chung Ying Leung; Ka Wing Lee; Woon Le 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

## Abstract ## Objective To study the incidence, predictors, and outcome of renal flares after successful cyclophosphamide (CYC) treatment for diffuse proliferative glomerulonephritis (DPGN) in patients with systemic lupus erythematosus (SLE). ## Methods Between 1988 and 2001, patients with biop

Histopathologic and clinical outcome of
Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis
✍ Iva Gunnarsson; Birgitta Sundelin; Thorunn Jónsdóttir; Stefan H. Jacobson; Elisa 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## Objective Rituximab is a monoclonal antibody directed against the CD20 marker of B cells. Because of its ability to deplete B lymphocytes, it has been suggested that the drug could be of benefit in B cell–dependent diseases, including systemic lupus erythematosus (SLE). The purpose

Treatment with cyclophosphamide delays t
Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis
✍ Cecile Grootscholten; Ingeborg M. Bajema; Sandrine Florquin; Eric J. Steenbergen 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 2 views

## Abstract ## Objective To analyze the effect of treatment with either pulse cyclophosphamide (CYC) or azathioprine (AZA) combined with methylprednisolone (MP), on serial biopsy results in patients with proliferative lupus nephritis, and to evaluate the predictive value of various histopathologic